首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.
【24h】

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.

机译:转铁蛋白受体第一部分:生物学和靶向细胞毒性抗体的治疗癌症。

获取原文
获取原文并翻译 | 示例
           

摘要

The transferrin receptor (TfR) is a cell membrane-associated glycoprotein involved in the cellular uptake of iron and in the regulation of cell growth. Iron uptake occurs via the internalization of iron-loaded transferrin (Tf) mediated by the interaction with the TfR. In addition, the TfR may also contain other growth regulatory properties in certain normal and malignant cells. The elevated levels of TfR in malignancies, its relevance in cancer, and the extracellular accessibility of this molecule make it an excellent antigen for the treatment of cancer using antibodies. The TfR can be targeted by monoclonal antibodies specific for the extracellular domain of the receptor. In this review, we summarize advancements in the basic physiology of the TfR including structure, function, and expression. We also discuss the efficacy of targeting the TfR using cytotoxic antibodies that inhibit cell growth and/or induce apoptosis in targeted malignant cells.
机译:转铁蛋白受体(TfR)是一种与细胞膜相关的糖蛋白,参与铁的细胞摄取和细胞生长的调节。铁吸收是通过与TfR相互作用介导的铁载运铁蛋白(Tf)的内在化而发生的。此外,TfR在某些正常和恶性细胞中还可能包含其他生长调节特性。 TfR在恶性肿瘤中的水平升高,与癌症的相关性以及该分子的细胞外可及性使其成为使用抗体治疗癌症的极佳抗原。 TfR可以被对受体胞外域具有特异性的单克隆抗体所靶向。在这篇综述中,我们总结了TfR的基本生理学进展,包括结构,功能和表达。我们还讨论了使用抑制细胞生长和/或诱导靶向恶性细胞凋亡的细胞毒性抗体靶向TfR的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号